Helsmoortel-Van der Aa Syndrome as emerging clinical diagnosis in intellectually disabled children with autistic traits and ocular involvement.

A recent syndromic condition with craniofacial dysmorphisms, comprising congenital ocular defect and neurodevelopmental delay named Helsmoortel-Van der Aa Syndrome (HVDAS) (OMIM#615873), has been described and molecularly defined, identifying pathogenic mutations in the ADNP gene (OMIM#611386) as biological cause. We report on two children, displaying intellectual disability (ID) and peculiar congenital eyes anomalies, both carrying a de novo nonsense mutation in the ADNP gene. The review of present and literature reports, suggests that the diagnosis of HVDAS should be suspected in patients with ID accompanied by behavioral features in the Autism Spectrum Disorder and distinctive craniofacial phenotype. Among dysmorphisms due to malformation of the periorbital region, ptosis appears to be particularly recurrent in HVDAS. Furthermore, the present patients could support the inclusion of the HVDAS associated with specific mutations clustering within a small ADNP genomic region among clinical conditions reminiscent of the blepharophimosis/mental retardation syndromes (BMRS).

[1]  Y. Gillerot,et al.  Blepharophimosis‐mental retardation (BMR) syndromes: A proposed clinical classification of the so‐called Ohdo syndrome, and delineation of two new BMR syndromes, one X‐linked and one autosomal recessive , 2006, American journal of medical genetics. Part A.

[2]  B. V. van Bon,et al.  Mutations in MED12 cause X-linked Ohdo syndrome. , 2013, American journal of human genetics.

[3]  H. Bassan,et al.  Complete Sequence of a Novel Protein Containing a Femtomolar‐Activity‐Dependent Neuroprotective Peptide , 1999, Journal of neurochemistry.

[4]  J. Clayton-Smith,et al.  Whole-exome-sequencing identifies mutations in histone acetyltransferase gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo syndrome. , 2011, American journal of human genetics.

[5]  A. Goldsweig,et al.  Activity-dependent neuroprotective protein: a novel gene essential for brain formation. , 2003, Brain research. Developmental brain research.

[6]  I. Gozes,et al.  Davunetide: Peptide therapeutic in neurological disorders. , 2014, Current medicinal chemistry.

[7]  I. Gozes,et al.  Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. , 2004, Neuron glia biology.

[8]  E. Seroussi,et al.  Cloning and Characterization of the Human Activity-dependent Neuroprotective Protein* , 2001, The Journal of Biological Chemistry.

[9]  C. Phornphutkul,et al.  Expansion of the clinical phenotype associated with mutations in activity-dependent neuroprotective protein , 2014, Journal of Medical Genetics.

[10]  D. Schlessinger,et al.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome , 2001, Nature Genetics.

[11]  Kali T. Witherspoon,et al.  A SWI/SNF related autism syndrome caused by de novo mutations in ADNP , 2014, Nature Genetics.

[12]  A. Jezela-Stanek,et al.  Additional data on the clinical phenotype of Helsmoortel—Van der Aa syndrome associated with a novel truncating mutation in ADNP gene , 2016, American journal of medical genetics. Part A.

[13]  Y. Sakamoto,et al.  Further evidence that a blepharophimosis syndrome phenotype is associated with a specific class of mutation in the ADNP gene , 2017, American journal of medical genetics. Part A.

[14]  Kali T. Witherspoon,et al.  Refining analyses of copy number variation identifies specific genes associated with developmental delay , 2014, Nature Genetics.

[15]  B. Coe,et al.  The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism , 2014, American journal of medical genetics. Part C, Seminars in medical genetics.

[16]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.